Detalles de la búsqueda
1.
Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer.
J Cell Physiol
; 234(2): 1768-1779, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30132876
2.
Stabilization of c-KIT G-Quadruplex DNA Structures by the RNA Polymerase I Inhibitors BMH-21 and BA-41.
Int J Mol Sci
; 20(19)2019 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31590335
3.
Immunotherapy-based combinations: an update.
Curr Opin Oncol
; 30(5): 345-351, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29994900
4.
A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.
Haematologica
; 103(8): 1351-1358, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29748443
5.
c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach.
Biochim Biophys Acta Gen Subj
; 1862(3): 615-629, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29229300
6.
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, Italy.
Cancer Immunol Immunother
; 71(7): 1777-1786, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34755203
7.
HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.
Blood
; 125(11): 1768-71, 2015 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25573990
8.
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
Br J Haematol
; 172(1): 111-21, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26458240
9.
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
Am J Hematol
; 91(5): E293-5, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26910388
10.
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.
Cancer Immunol Immunother
; 69(6): 1141-1151, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32025818
11.
Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.
Int J Cancer
; 135(9): 2034-45, 2014 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24648290
12.
Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy.
Future Oncol
; 10(16): 2569-78, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24947121
13.
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade.
Sci Rep
; 14(1): 3379, 2024 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38336861
14.
Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFß) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors.
Clin Transl Sci
; 17(2): e13736, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38362837
15.
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.
Blood
; 118(16): 4421-30, 2011 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21860023
16.
Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat.
Hematol Oncol
; 36(1): 360-362, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28730742
17.
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
Br J Haematol
; 158(1): 108-19, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571717
18.
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.
Blood
; 115(11): 2231-40, 2010 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-20075160
19.
Targeted protein degraders from an oncologist point of view: The Holy Grail of cancer therapy?
Crit Rev Oncol Hematol
; 169: 103532, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34800655
20.
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer.
Cell Oncol (Dordr)
; 45(2): 257-274, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35357654